1. Home
  2. WFRD vs BLCO Comparison

WFRD vs BLCO Comparison

Compare WFRD & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weatherford International plc

WFRD

Weatherford International plc

HOLD

Current Price

$96.22

Market Cap

6.0B

Sector

Industrials

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$17.98

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WFRD
BLCO
Founded
1941
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Metal Fabrications
Ophthalmic Goods
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.0B
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
WFRD
BLCO
Price
$96.22
$17.98
Analyst Decision
Buy
Buy
Analyst Count
8
12
Target Price
$93.25
$18.55
AVG Volume (30 Days)
1.0M
452.4K
Earning Date
05-04-2026
05-21-2026
Dividend Yield
1.12%
N/A
EPS Growth
N/A
N/A
EPS
5.93
N/A
Revenue
$4,331,000,000.00
$5,101,000,000.00
Revenue This Year
$0.37
$7.45
Revenue Next Year
$3.48
$5.49
P/E Ratio
$16.40
N/A
Revenue Growth
N/A
6.47
52 Week Low
$36.74
$10.45
52 Week High
$110.57
$18.92

Technical Indicators

Market Signals
Indicator
WFRD
BLCO
Relative Strength Index (RSI) 43.72 56.53
Support Level $68.68 $16.35
Resistance Level $106.38 $18.92
Average True Range (ATR) 3.58 0.64
MACD -1.44 0.03
Stochastic Oscillator 8.13 64.91

Price Performance

Historical Comparison
WFRD
BLCO

About WFRD Weatherford International plc

Weatherford provides oilfield services and equipment to national, integrated, public, and private oil and gas operators. It operates across multiple upstream markets, including offshore, the rest of the world onshore, and US onshore, where Weatherford has limited exposure. The Middle East, North Africa, and Asia account for over 25% of sales. Weatherford also offers manufacturing, research, and training services. Performance is reported through three segments: drilling and evaluation, well construction and completions, and production and intervention.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: